Lucid Diligence Brief - Tech

Lucid Diligence Brief: HealthVerity and Claritas Rx partnership

Lucid Diligence Brief: HealthVerity and Claritas Rx partnership Professional…


Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap — October 20, 2025

This biweekly video summary highlights global updates in AI in Healthcare and…


Artificial_Intelligence

AI in Healthcare and Digital Health Today — October 20, 2025

From smarter diagnostics to data-driven decision-making, this weekly roundup…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B

Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kardigan $254m Series B

Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia

Lucid Diligence Brief: Samsung and GRAIL LOI, Galleri MCED rollout in Asia…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: EVOQ x Sanofi collaboration

Lucid Diligence Brief: EVOQ x Sanofi collaboration Professional audiences only.…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design collaboration

Lucid Diligence Brief: Nabla Bio and Takeda, second AI protein-design…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040

Lucid Diligence Brief: Tubulis €308m Series C, NaPi2b ADC TUB-040 Professional…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Verily UCHealth AI collaboration

Lucid Diligence Brief: Verily UCHealth AI collaboration Professional audiences…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kailera Therapeutics $600m Series B

Lucid Diligence Brief: Kailera Therapeutics $600m Series B Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Excellergy ECRIs, $70M investment

Lucid Diligence Brief: Excellergy ECRIs, $70M investment Professional audiences…


Privacy Preference Center